Navigation Links
Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
Date:4/26/2012

results of the second trial are pending, the current intention is not to pursue a regulatory filing for this indication for MMX mesalamine.

Lisdexamfetamine dimesylate ("LDX") (currently marketed as VYVANSE in the US for the treatment of ADHD) for the treatment of Binge Eating Disorder ("BED")

  • Today, Shire announced Phase 2 results from an efficacy and safety clinical study of LDX for the treatment of BED. In this study, in which the pre-defined primary end point was met, treatment of adults with LDX resulted in a statistically significant reduction in binge eating behaviour and increased remission rates from binge eating compared to placebo. There is currently no approved pharmacologic treatment for patients struggling with BED, the most common eating disorder.

FIRST QUARTER AND RECENT BUSINESS DEVELOPMENT ACTIVITY

Since the beginning of the year we have added to our pipeline through the following transactions:


Acquisition of FerroKin Biosciences, Inc. ("FerroKin")

  • On April 2, 2012 Shire completed the acquisition of FerroKin and with it SPD 602 (formally referred to as FBS0701), FerroKin's iron chelator treatment in Phase 2 development. SPD 602 serves a chronic patient need for treatment of iron overload following numerous blood transfusions. Together with our collaboration with Sangamo Biosciences Inc. ("Sangamo"), the acquisition of FerroKin represents a strategic step in building Shire's hematology business, which already includes XAGRID® and a growing development pipeline, including SPD 535. Cash consideration paid on closing amounted to $94.5 million. Further contingent cash consideration of up to $225 million may be payable by Shire in future periods, dependent upon the achievement of certain clinical development, regulatory and net sales milestones.

Acquisition of certain assets
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
3. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
5. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
6. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
7. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
8. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
9. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
10. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
11. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)...  For many businesses and industries just one day ... having the right management software can be an absolute ... software solutions company TraxStar Technologies , creators of ... announced the release of the newest version of QATrax ... "QATrax is hugely ...
(Date:4/1/2015)... -- Philips Respironics, a division of Royal Philips (NYSE: ... nasal mask is now available in the ... apnea (OSA). Designed to maximize comfort and effectiveness, Pico is ... mask available on the market to treat OSA*. Philips Pico, ... on display at Medtrade Spring (Booth #235) in ...
(Date:4/1/2015)... , April 1, 2015 MEI Pharma, Inc. (Nasdaq: ... development of novel therapies for cancer, announced today that ... will present at the 14 th Annual Needham Healthcare ... time from the Westin Grand Central Hotel in ... can be accessed at www.meipharma.com . A replay will ...
Breaking Medicine Technology:TraxStar Technologies Announces Latest QATrax Test Lab Management Software Now Available 2Philips Pico CPAP Nasal Mask Now Available in the United States 2Philips Pico CPAP Nasal Mask Now Available in the United States 3MEI Pharma to Present at Needham Healthcare Conference 2
... Researcher at American Academy of Ophthalmology Annual Meeting Describes ... Advance in Treatment of Endothelial ... research presentation today,at the American Academy of Ophthalmology,s Annual ... at the Villa Serena,Hospital, Forli, Italy, described a technique ...
... Ellex Medical Lasers Limited,(ASX: ELX), a global ... and ultrasound systems, announced today initial clinical results ... (Ellex,2RT(TM)). Results demonstrate the therapy,s potential to improve ... in patients with,diabetic maculopathy and macular edema without ...
Cached Medicine Technology:Improved Cornea Surgery Technique Provides Enhanced Transplant Success 2Ellex 2RT Study Demonstrates Clinical Efficacy in Treatment of Diabetic Macular Edema 2Ellex 2RT Study Demonstrates Clinical Efficacy in Treatment of Diabetic Macular Edema 3Ellex 2RT Study Demonstrates Clinical Efficacy in Treatment of Diabetic Macular Edema 4
(Date:4/1/2015)... 2015 BioPlus Specialty Pharmacy ... has released a new app to keep health care ... chronic hepatitis C virus (HCV) infection. This ‘HCV Treatment ... from the American Association for the Study of Liver ... new direct-acting oral medications to treat HCV have been ...
(Date:4/1/2015)... Dr. Daniel C. Stewart will be ... the benefits of the LANAP® treatment over traditional ... People who live in Howard County, and surrounding areas ... visit Dr. Stewart, a Maryland dentist, for a minimally ... protocol, which is a laser gum surgery procedure, Dr. ...
(Date:4/1/2015)... 2015 OSF Saint Paul Medical Center, ... , was welcomed into the Ministry April 1, 2015, ... Paul E. Showalter, vicar general of the Catholic Diocese ... culminated a nearly year-long transition process for the former ... Speakers for the morning ceremony included Sister Judith Ann ...
(Date:4/1/2015)... 2015 Aging2.0 , the global ... the launch of the Aging2.0 Alliance – ... and technology companies. The announcement was made today at ... Business Strategies Forum in San Diego, CA. ... program is now open for additional members. “This is ...
(Date:4/1/2015)... April 01, 2015 Dr. Rod ... Distinguished Teaching Professor of the Department of Plastic Surgery ... doctors to review reports of blindness resulting from the ... . The group published their study, along with ideas ... Surgery journal. , "We began to see increasing reports ...
Breaking Medicine News(10 mins):Health News:BioPlus Specialty Pharmacy Releases ‘HCV Treatment Path’ App for Hepatitis C Providers 2Health News:Dr. Daniel C. Stewart Offers Columbia Area Residents an Informational Seminar in April About Less Invasive Gum Disease Treatment Now Available at Smile Savers Dentistry 2Health News:Dr. Daniel C. Stewart Offers Columbia Area Residents an Informational Seminar in April About Less Invasive Gum Disease Treatment Now Available at Smile Savers Dentistry 3Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 2Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 3Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 2Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 3Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 4Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 2Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 3
... Eldik, director of the University of Kentucky Sanders-Brown Center on ... research into a possible treatment for Alzheimer,s disease. The grant ... Foundation, and was one of only eight Awards in Alzheimer,s ... in 2010. Van Eldik,s research project focuses on developing ...
... MONDAY, Jan. 24 (HealthDay News) -- The anti-estrogen drug that ... also reduce the risk of dying from lung cancer, researchers ... online edition of the journal Cancer , tamoxifen lowered ... already had breast cancer. However, the results are too ...
... This release is available in French . ... Timothy Geary received a $1-million grant today for landmark ... African biodiversity. Grand Challenges Canada, Canada,s International Development ... the Bill & Melinda Gates Foundation have joined together ...
... Reinberg HealthDay Reporter , SUNDAY, Jan. 23 (HealthDay ... may be delayed until the end of this week because ... said Saturday. Dr. John Holcomb, a trauma surgeon and ... have to decide whether a catheter draining the fluid can ...
... -- By this point, New Year,s resolutions might be a ... fine-tuning, especially for those who resolved to lose weight. ... Denver, suggests using what she calls the "SMART" system to ... for goals that are specific, measurable, attainable, realistic and timely. ...
... deciphered the genetic code for a type of pancreatic cancer, ... in the Jan. 20 issue of Science Express, ... twice as long as those without them. "One of ... with this kind of rare cancer has a unique genetic ...
Cached Medicine News:Health News:Breast Cancer Drug May Also Help Lung Cancer Patients 2Health News:McGill awarded $1-million grant to address debilitating parasitic diseases in the developing world 2Health News:McGill awarded $1-million grant to address debilitating parasitic diseases in the developing world 3Health News:Rep. Giffords Set to Begin Rehab in Houston 2Health News:Rep. Giffords Set to Begin Rehab in Houston 3Health News:Rep. Giffords Set to Begin Rehab in Houston 4Health News:How to Get Smart About Weight Loss 2Health News:Johns Hopkins scientists crack genetic code for form of pancreatic cancer 2Health News:Johns Hopkins scientists crack genetic code for form of pancreatic cancer 3
Provides quick access to information needed to make diagnoses and treatment decisions....
PDA format of the well-known standard antimicrobial reference....
PDA application containing all 7,000+ Physicians' Current Procedural Terminology codes developed by the American Medical Association....
PDA application providing a complete guide for the diagnosis and management of electrolyte disorders....
Medicine Products: